S Gastrointestinal And Liver Disease 12th Edition • Editor's Choice

: New discussions on using AI in endoscopy to enhance the detection of gastrointestinal cancers. Major Clinical Updates Liver Disease Nomenclature : Transition to the term

With the rise of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—formerly NAFLD—and breakthroughs in Hepatitis C and cirrhosis management, the liver sections have been significantly expanded to provide the most current clinical pathways. 4. Minimally Invasive Innovations s gastrointestinal and liver disease 12th edition

Often referred to simply as Sleisenger and Fordtran’s , the 12th edition remains the definitive, encyclopedic reference for physicians, fellows, and residents in gastroenterology and hepatology. Published in 2020 by Elsevier, this two-volume set continues the legacy of providing comprehensive, evidence-based, and clinically actionable information on the entire spectrum of digestive disorders. The 12th edition arrives at a time of rapid advancements in gut microbiome research, immunotherapy for liver disease, and minimally invasive endoscopic techniques, all of which are thoroughly integrated into this update. : New discussions on using AI in endoscopy

The of Sleisenger and Fordtran's Gastrointestinal and Liver Disease Minimally Invasive Innovations Often referred to simply as